The FDA OKs Pfizer-BioNTech Booster For People 65+ And At High Risk For Severe COVID

Posted by on September 22, 2021 7:52 pm
Categories: US National Stories

Rufus Peoples receives a dose of the Pfizer-BioNTech COVID-19 vaccine at a vaccination clinic in Southfield, Mich., in August.

A third shot of the vaccine can be given at least six months after the two-dose regimen, according to the authorization. A booster rollout could begin this week.

(Image credit: Emily Elconin/Getty Images)

Leave a Reply

Your email address will not be published.